Mrs Potato head and her spuds

Quote


















anonymous said:
"Enzo Biochem’s Life Sciences Products reporting unit operates in one reportable segment, Products"
I thought this is a diagnostics company... nothing like being disappointed, and lied to as well.
Therapeutics... diagnostics... sold those loosers
BUT Still Losing
Click to expand...
How can it be that quarter after quarter the same old disastrous financials. KC is no different from paranoid Elazar and his worthless projects. It's only a matter of time before a change of leadership will take place.
 






anonymous said:
KC has already damaged the place to the point of no return. Wait and see what happens when an idiot phony and her team of losers try to run a business.
Click to expand...
Wait wait for it ten cents x dividend 11/15, time to get out.
Read "Since our exit from the clinical lab business, Enzo has delivered on the objectives set last year to stabilize revenue"
Exit sign in RED
 






Its an aging product line with expensive sunk costs, not a dynamic life sci business. The new product line is virtually dead - Rabinni was the brains of the operation. A brilliant scientist but a horrible human being and CEO. This is simply a sophisticated catalogue business. The fourth qt drop of 17% in sales revenue says it all. If it sells, it will likely go for 1 -1.5 X revenue. And they still have outstanding litigation settlement to dole out - which further eats into the long term viability.
 






anonymous said:
Its an aging product line with expensive sunk costs, not a dynamic life sci business. The new product line is virtually dead - Rabinni was the brains of the operation. A brilliant scientist but a horrible human being and CEO. This is simply a sophisticated catalogue business. The fourth qt drop of 17% in sales revenue says it all. If it sells, it will likely go for 1 -1.5 X revenue. And they still have outstanding litigation settlement to dole out - which further eats into the long term viability.
Click to expand...
Sad, sad, sad
Who is perspective buyer.
Someone who wants this dream team
 






My guess is there either is no buyer or… the price is a very low multiple. The patents are pretty much worthless and aging out. There is zero demand for manufacturing facilities in general, and certainly not one in expensive Long Island. I would not be surprised if it gets delisted. The Board chair is a blockhead too.
 




































Top Bottom
Back
Quote